For: | Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes 2023; 14(6): 724-740 [PMID: 37383601 DOI: 10.4239/wjd.v14.i6.724] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i6/724.htm |
Number | Citing Articles |
1 |
Tian-Yu Wang, Qiang Yang, Xin-Yi Cheng, Jun-Can Ding, Peng-Fei Hu. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction. Heart Failure Reviews 2024; doi: 10.1007/s10741-024-10438-2
|
2 |
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang. Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction. Reviews in Cardiovascular Medicine 2024; 25(9) doi: 10.31083/j.rcm2509311
|
3 |
Ruijue Huang, Wenjia Li, Zhen Xie, Kaimin Zhuo, Jing Zhu. Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without Diabetes. Academic Radiology 2024; 31(9): 3546 doi: 10.1016/j.acra.2024.04.001
|
4 |
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
|
5 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov. Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters. Diabetes mellitus 2024; 27(4): 357 doi: 10.14341/DM13189
|